ARTICLE | Company News
Rosetta Genomics sales and marketing update
May 21, 2012 7:00 AM UTC
Rosetta launched its miRview kidney in the U.S. The molecular diagnostic is used to classify four kidney tumors: benign oncocytoma and clear cell, papillary and chromophobe renal cell carcinoma. ...